-The Indian Express Srinagar: A day after an elderly woman was allegedly beaten to death by the police after raiding her house in south Kashmir, the Jammu and Kashmir Police have arrested two of their men as well as the woman’s son-in-law for dumping a banned herb in her house. However, the two policemen have been booked for only minor offence, and no case pertaining to murder, assault and intrusion has...
More »SEARCH RESULT
Total Matching Records found : 252
Give them their rights -Thomas Chandy
-The Hindustan Times Amid the din of the discordant notes in Parliament and outside on scams, a significant decision by the Union cabinet went almost unnoticed. Earlier this week, the Cabinet amended the Child Labour Prohibition and Regulation Act (CLPRA), 1986, and renamed it as the Child and Adolescent Labour Prohibition Act (CALPA). When Parliament passes the important amendments, CALPA, along with the Right to Education (RTE) Act, it is likely...
More »Process of Clinical Trial to Be Streamlined Further: Govt
-PTI Procedures for clinical trials in India will be further streamlined and a panel of experts set up to analyse the cause of Injury or death and to recommend quantum of compensation to victims, the Government today said. Replying to a Calling Attention Motion on the issue in Rajya Sabha, Health and Family Welfare Minister Ghulam Nabi Azad said the government proposed to strengthen the rules by incorporating certain new provisions soon. He...
More »Government warns PATH -Aarti Dhar
-The Hindu The government has issued a warning letter to Programme for Appropriate Technology in Health (PATH), asking it to be careful while conducting clinical trials so as to ensure that discrepancies and violations are not repeated in future. The Indian Council of Medical Research (ICMR) had suspended the Phase-V post licensure clinical trial being conducted by PATH, an international non-governmental organisation, in Khamman (Andhra Pradesh) and Vadodara (Gujarat) for Human Papilloma...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
